Tabula Rasa HealthCare Inc (TRHC) CEO Calvin H. Knowlton Sells 8,000 Shares

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction on Monday, January 7th. The stock was sold at an average price of $63.06, for a total transaction of $504,480.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Shares of NASDAQ:TRHC opened at $66.02 on Friday. The firm has a market cap of $1.25 billion, a PE ratio of -1,650.50, a price-to-earnings-growth ratio of 3.89 and a beta of 2.45. The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28. Tabula Rasa HealthCare Inc has a 52 week low of $28.55 and a 52 week high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. The company had revenue of $54.42 million for the quarter, compared to analyst estimates of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. Tabula Rasa HealthCare’s revenue was up 66.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.08 earnings per share. Equities analysts anticipate that Tabula Rasa HealthCare Inc will post 0.42 earnings per share for the current year.

A number of analysts have weighed in on the stock. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $69.00 target price on the stock in a research note on Thursday. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research note on Wednesday, November 28th. Citigroup boosted their target price on shares of Tabula Rasa HealthCare to $100.00 and gave the stock a “buy” rating in a research note on Thursday, October 11th. Piper Jaffray Companies reiterated an “overweight” rating and set a $80.00 price target on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. Finally, Robert W. Baird lifted their price target on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, September 19th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $82.27.

Several large investors have recently modified their holdings of the company. BlackRock Inc. lifted its holdings in shares of Tabula Rasa HealthCare by 20.8% during the third quarter. BlackRock Inc. now owns 2,560,710 shares of the company’s stock worth $207,904,000 after purchasing an additional 441,203 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Tabula Rasa HealthCare by 6.9% during the third quarter. Vanguard Group Inc. now owns 967,769 shares of the company’s stock worth $78,573,000 after purchasing an additional 62,267 shares during the period. Vanguard Group Inc lifted its holdings in shares of Tabula Rasa HealthCare by 6.9% during the third quarter. Vanguard Group Inc now owns 967,769 shares of the company’s stock worth $78,573,000 after purchasing an additional 62,267 shares during the period. NN Investment Partners Holdings N.V. lifted its holdings in Tabula Rasa HealthCare by 45.2% in the third quarter. NN Investment Partners Holdings N.V. now owns 669,800 shares of the company’s stock valued at $54,380,000 after buying an additional 208,604 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Tabula Rasa HealthCare by 20.8% in the third quarter. Bank of New York Mellon Corp now owns 258,613 shares of the company’s stock valued at $20,996,000 after buying an additional 44,551 shares during the period. Institutional investors own 74.87% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was first posted by WKRB News and is owned by of WKRB News. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.wkrb13.com/2019/01/11/tabula-rasa-healthcare-inc-trhc-ceo-calvin-h-knowlton-sells-8000-shares.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: How liquidity affects the bid-ask spread

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply